Search hospitals > British Columbia > VANCOUVER

British Columbia Children's Hospital

Claim this profile
VANCOUVER, British Columbia V6H 3V4
Global Leader in Leukemia
Global Leader in Lymphoblastic Leukemia-Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Tumors
Conducts research for Lymphoid Leukemia
331 reported clinical trials
21 medical researchers
Photo of British Columbia Children's Hospital in VANCOUVERPhoto of British Columbia Children's Hospital in VANCOUVERPhoto of British Columbia Children's Hospital in VANCOUVER

Summary

British Columbia Children's Hospital is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Tumors, Lymphoid Leukemia and other specialties. British Columbia Children's Hospital is involved with conducting 331 clinical trials across 564 conditions. There are 21 research doctors associated with this hospital, such as David B. Dix, Kevan Jacobson, Kishore Mulpuri, FRCSC, and Kathryn Selby, MD.

Area of expertise

1Leukemia
Global Leader
British Columbia Children's Hospital has run 52 trials for Leukemia. Some of their research focus areas include:
Stage II
Stage IV
Stage III
2Lymphoblastic Leukemia-Lymphoma
Global Leader
British Columbia Children's Hospital has run 35 trials for Lymphoblastic Leukemia-Lymphoma. Some of their research focus areas include:
Stage II
Stage IV
Stage III

Top PIs

Clinical Trials running at British Columbia Children's Hospital

Acute Myeloid Leukemia
Crohn's Disease
Ulcerative Colitis
Leukemia
Myelodysplastic Syndrome
Ovarian Tumors
Inflammatory Bowel Disease
Ulcer
Testicular Carcinoma
Ovarian Carcinoma
Image of trial facility.

Stem Cell Transplantation

for Leukemia

This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical \[haplo\]) versus matched unrelated donors (MUD) in treating children, adolescents, and young adults with acute leukemia or myelodysplastic syndrome (MDS). HCT is considered standard of care treatment for patients with high-risk acute leukemia and MDS. In HCT, patients are given very high doses of chemotherapy and/or radiation therapy, which is intended to kill cancer cells that may be resistant to more standard doses of chemotherapy; unfortunately, this also destroys the normal cells in the bone marrow, including stem cells. After the treatment, patients must have a healthy supply of stem cells reintroduced or transplanted. The transplanted cells then reestablish the blood cell production process in the bone marrow. The healthy stem cells may come from the blood or bone marrow of a related or unrelated donor. If patients do not have a matched related donor, doctors do not know what the next best donor choice is. This trial may help researchers understand whether a haplo related donor or a MUD HCT for children with acute leukemia or MDS is better or if there is no difference at all.
Recruiting2 awards Phase 3
Image of trial facility.

Venetoclax + Chemotherapy

for Acute Myeloid Leukemia

This trial is testing whether adding venetoclax to standard chemotherapy can help young patients with relapsed AML. Venetoclax works by blocking a protein that helps cancer cells survive, making it easier for the chemotherapy to kill them. The study aims to find better treatment options for these patients who have limited choices. Venetoclax has been shown to improve overall survival in older and unfit patients with newly diagnosed acute myeloid leukemia when combined with lower intensity therapies.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Diagnostic Testing

for Pediatric Leukemia

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
Recruiting1 award Phase 1 & 211 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at British Columbia Children's Hospital?
British Columbia Children's Hospital is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Tumors, Lymphoid Leukemia and other specialties. British Columbia Children's Hospital is involved with conducting 331 clinical trials across 564 conditions. There are 21 research doctors associated with this hospital, such as David B. Dix, Kevan Jacobson, Kishore Mulpuri, FRCSC, and Kathryn Selby, MD.
Where is British Columbia Children's Hospital located?
**BC Children's Hospital Location and Access:** - **Address:** 4480 Oak St, Vancouver, BC. - **Entrances:** Use Entrance #42, #46, or #21. - **Directions Inside:** Take the elevators to the third floor and follow the orange line.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at British Columbia Children's Hospital, contact the Medical Benefits program at 1-888-613-3232 (toll-free) or 250-387-9649 (Victoria). This program supports eligible children and teens with complex health needs by providing medical and bio-medical equipment, orthotics, splints, audiology supplies, medical supplies, extended therapies, dental/orthodontic and optical benefits, medical transportation, and Medical Services Plan coverage. The PharmaCare program offers coverage for prescription medications, orthotics, prosthetics, diabetic supplies, and blood glucose testing strips, while incontinence supplies funding is accessible through a Request for Medical Supplies Form or by calling 1-888-613-3232.
What insurance does British Columbia Children's Hospital accept?
BC Children's Hospital specializes in caring for the most seriously ill or injured children from across British Columbia. Families from outside Metro Vancouver with a child requiring care at BC Children's Hospital may be eligible for travel and accommodation support through the BC Family Residence Program. For detailed information about insurance plans accepted, please contact BC Children's Hospital directly or visit their website.
What awards or recognition has British Columbia Children's Hospital received?
British Columbia Children's Hospital Research Institute, located in Vancouver, British Columbia, is renowned for its groundbreaking research in child health, aiming to prevent, treat, and cure complex health conditions, developmental disorders, and chronic diseases originating in childhood. The institute boasts over 1,000 researchers and receives support from the BC Children's Hospital Foundation, Provincial Health Services Authority, and the University of British Columbia. Its funding priorities include research trainee awards for projects that directly improve the health of children and their families.